Telephone-administered cognitive behavioral therapy: A case study of anxiety and depression in Parkinson's disease

Connie Veazey, Karon F. Cook, Melinda Stanley, Eugene C. Lai, Mark E. Kunik

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Abstract

Parkinson's disease (PD) is a chronic medical illness with a high incidence of psychiatric comorbidity, specifically depression and anxiety. Research on treatment of such psychiatric complications is scarce. Non-pharmaceutical treatment options are especially attractive. Cognitive behavioral therapy (CBT) is a psychotherapeutic treatment option that has been successful in other chronically medically ill populations with comorbid depression and anxiety. The current research had two aims. The first was to pilot the feasibility of screening and identifying PD patients with symptoms of anxiety and depression in a specialized outpatient clinic. The second aim was to pilot the feasibility of telephone-administered CBT for the treatment of depression and anxiety in persons with PD, which was done through a case series comparing telephone-administered CBT to a Support strategy. A fairly large portion (67.5%) of patients screened in the outpatient clinic were identified as having symptoms of anxiety and/or depression. Results also indicated that CBT delivered via the telephone is a useful approach for targeting psychiatric symptoms in this population. A case example is given to illustrate the clinical considerations associated with delivering therapy via telephone to persons with PD.

Original languageEnglish (US)
Pages (from-to)243-253
Number of pages11
JournalJournal of Clinical Psychology in Medical Settings
Volume16
Issue number3
DOIs
StatePublished - 2009

Keywords

  • Anxiety
  • Chronic illness
  • Cognitive behavioral therapy
  • Depression
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Psychology

Fingerprint

Dive into the research topics of 'Telephone-administered cognitive behavioral therapy: A case study of anxiety and depression in Parkinson's disease'. Together they form a unique fingerprint.

Cite this